Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Study to Test the Safety and Efficacy of Ustekinumab in Patients With Giant Cell Arteritis

NCT02955147 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02955147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02955147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Study to Test the Safety and Efficacy of Ustekinumab in Patients With Giant Cell Arteritis
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1/2
Overall status
Terminated
Start date
December 1, 2016
Completion date
September 19, 2019
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

giant cell arteritis, horton's disease, temporal arteritis